![Joakim Grånemo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joakim Grånemo
Directeur Général chez
ALPHAHELIX MOLECULAR DIAGNOSTICS AB
Profil
Joakim Grånemo is Chief Executive Officer & Director at Level Bio AB since 2023 and Chief Executive Officer at CyberGene AB since 2022.
Formerly, Mr. Grånemo was Global Product Manager at CareDx AB from 2018 to 2020.
Postes actifs de Joakim Grånemo
| Sociétés | Poste | Début |
|---|---|---|
| ALPHAHELIX MOLECULAR DIAGNOSTICS AB | Directeur Général | 23/08/2023 |
CyberGene AB
 CyberGene AB Medical SpecialtiesHealth Technology Develops and manufactures ChromoQuant CE-IVD kits used for prenatal diagnosis and diagnostics of male infertility | Directeur Général | 01/06/2022 |
Anciens postes connus de Joakim Grånemo
| Sociétés | Poste | Fin |
|---|---|---|
CareDx AB
 CareDx AB BiotechnologyHealth Technology Operates as a precision medicine company that develops healthcare solutions for transplant patients and caregivers | Corporate Officer/Principal | 01/06/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Level Bio AB
 Level Bio AB Medical DistributorsDistribution Services Develops and manufactures instruments for deoxyribonucleic acid analysis | Distribution Services |
CyberGene AB
CyberGene AB Medical SpecialtiesHealth Technology Develops and manufactures ChromoQuant CE-IVD kits used for prenatal diagnosis and diagnostics of male infertility | Health Technology |
CareDx AB
CareDx AB BiotechnologyHealth Technology Operates as a precision medicine company that develops healthcare solutions for transplant patients and caregivers | Health Technology |
Choisissez Zonebourse 
